Horizon Therapeutics plc to Release Third-Quarter 2021 Financial Results and Host Webcast on Nov. 3, 2021

Rhea-AI Summary

Horizon Therapeutics plc (Nasdaq: HZNP) is set to release its third-quarter 2021 financial results on November 3, 2021, at 8 a.m. Eastern Time. Following this, a live webcast will be available for management to discuss the financial and operational outcomes. Investors can access the webcast via Horizon's investor relations website. Horizon focuses on developing treatments for rare, autoimmune, and severe inflammatory diseases, emphasizing the integration of science and compassion to profoundly impact patients' lives.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2021 financial results will be released on Wednesday, Nov. 3, 2021. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.

The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay of the webcast will be available approximately two hours after the live webcast.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211011005162/en/

Investors:

Tina Ventura

Senior Vice President,

Investor Relations

investor-relations@horizontherapeutics.com



Ruth Venning

Executive Director,

Investor Relations

investor-relations@horizontherapeutics.com



U.S. Media:

Geoff Curtis

Executive Vice President,

Corporate Affairs & Chief Communications Officer

media@horizontherapeutics.com



Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When will Horizon Therapeutics release its third-quarter 2021 financial results?

Horizon Therapeutics will release its third-quarter 2021 financial results on November 3, 2021.

What time is the Horizon Therapeutics Q3 2021 financial results webcast?

The webcast for Horizon Therapeutics' Q3 2021 financial results will take place at 8 a.m. Eastern Time.

Where can I access the Horizon Therapeutics Q3 2021 results webcast?

The webcast can be accessed on Horizon Therapeutics' investor relations website.

What is Horizon Therapeutics focused on in its business operations?

Horizon Therapeutics focuses on the discovery, development, and commercialization of medicines for rare, autoimmune, and severe inflammatory diseases.